Prima Closes $9.2 Million Seed and Financing

Prima offers skin care, body care and supplements with organic, broad spectrum plant ingredients.
Prima offers skin care, body care and supplements with organic, broad spectrum plant ingredients.

The Uplifters' Prima, PBC (Prima) has announced the close of a $9.2 million seed, plus financing led by leading institutional venture firms Greycroft, H Ventures, Defy and Lerer Hippeau.

Related: Prima First to Offer EWG Verified CBD Products

Notable participation comes from Adam Zeplain, Global Founders Capital, Emerald Health, One Gun and Purple Arch Ventures.

The funding will support sustainable growth, upcoming retail expansions, remedy-focused clinical research, portfolio refinements and education initiatives.

The new strategic investment from Emerald Health Therapeutics offers Prima access to proprietary cannabinoid, patent holdings and medical-grade cultivation. 

Christopher Gavigan, Prima's founder and CEO, said, "As an experienced team building a CPG platform of the highest integrity, credibility, consciousness and quality, we realize it is our duty and responsibility to impose uncompromising and rigorous standards and boldly self-regulate to lead this emerging functional wellness industry forward. With this meaningful funding, Prima will continue its focused investments in plant-driven, clean formulation science, R&D ownership, efficacy validation, operational infrastructure, sustainability initiatives and tech-enabled consumer experiences. Prima is even more emboldened to broaden our digital and retail strategies, build best-in-class education partnerships and ensure these therapeutic botanical compounds are destigmatized, understood and accessible for all."

Laurel Angelica Myers, Prima's co-founder and COO, said, "Our team brings institutional strategy, sophistication, capability and execution to a burgeoning sector that has yet to see any brands like Prima. As a Certified B Corporation that is Carbon and Plastic Neutral Certified and EWG Verified, Prima is built on strong, sophisticated, sustainable infrastructure across every touchpoint of the business."

Jessica Assaf, Prima's co-founder and chief education officer, said, "With so many new brands entering the CBD market, we strongly invite and encourage the FDA and Congressional regulators to legislate and be more proactive in taking swifter action to protect consumer safety, which in turn will further accelerate the acceptance and advancement of this critical health care industry."

More in News